12.46

0.56% 0.07

Avid Bioservices Inc (CDMO)

Overview News Price History Option Chain Financials Why CDMO Down? Discussions Forecast Stock Split

Avid Bioservices Inc stock is traded at $12.46, with a volume of 1.50M. It is up +0.56% in the last 24 hours and up +1.30% over the past month. Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Previous Close:

$12.39

Open:

$12.4

24h Volume:

1.50M

Relative Volume:

0.77

Market Cap:

$796.98M

Revenue:

$139.91M

Net Income/Loss:

$-140.75M

P/E Ratio:

-5.638

EPS:

-2.21

Net Cash Flow:

$-20.85M

1W Performance:

+0.32%

1M Performance:

+1.30%

6M Performance:

+31.85%

1Y Performance:

+100.97%

1-Day Range:

$12.39

$12.46

1-Week Range:

$12.37

$12.46

52-Week Range:

$5.90

$12.48

Avid Bioservices Inc Stock (CDMO) Company Profile

Name

Avid Bioservices Inc

Sector

Healthcare (1176)

Industry

Biotechnology (685)

Phone

714.508.6100

Address

14191 MYFORD ROAD, TUSTIN, CA

Employee

371

Twitter

Next Earnings Date

2024-09-09

Latest SEC Filings

CDMO's Discussions on Twitter

Compare CDMO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDMO Avid Bioservices Inc	12.46	796.98M	139.91M	-140.75M	-20.85M	-2.21
VRTX Vertex Pharmaceuticals Inc	427.89	110.19B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	687.80	75.58B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	647.39	38.71B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	264.99	34.18B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.25	28.11B	3.30B	-501.07M	1.03B	-2.1146

Avid Bioservices Inc Stock (CDMO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-28-23	Initiated	William Blair	Mkt Perform
Mar-14-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Dec-08-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-17-21	Initiated	RBC Capital Mkts	Outperform
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-10-19	Upgrade	First Analysis Sec	Outperform → Strong Buy
Oct-17-19	Initiated	Stephens	Overweight
Oct-16-19	Initiated	Craig Hallum	Buy
Jun-28-19	Upgrade	Janney	Neutral → Buy
May-09-19	Downgrade	Janney	Buy → Neutral

View All

Avid Bioservices Inc Stock (CDMO) Latest News

Jan 21, 2025

Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis -January 21, 2025 at 08:00 am EST - Marketscreener.com

Jan 21, 2025

Avid Recommends Stockholders Follow Recommendations of ISS - GlobeNewswire

Jan 21, 2025

Jan 19, 2025

(CDMO) Proactive Strategies - Stock Traders Daily

Jan 19, 2025

Jan 17, 2025

Proxy adviser ISS said to recommend Avid Bioservices holders vote for takeover - MSN

Jan 17, 2025

Jan 15, 2025

Avid Bioservices (NASDAQ:CDMO) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Jan 15, 2025

Jan 13, 2025

Insider Selling: Avid Bioservices, Inc. (NASDAQ:CDMO) Insider Sells 2,283 Shares of Stock - MarketBeat

Jan 13, 2025

Avid Bioservices COO Richard Richieri sells shares worth $30,714 By Investing.com - Investing.com Australia

Jan 13, 2025

Avid Bioservices COO Richard Richieri sells shares worth $30,714 - Investing.com

Jan 13, 2025

Barclays PLC Acquires 66,653 Shares of Avid Bioservices, Inc. (NASDAQ:CDMO) - Defense World

Jan 13, 2025

Barclays PLC Boosts Position in Avid Bioservices, Inc. (NASDAQ:CDMO) - MarketBeat

Jan 13, 2025

Jan 12, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Avid Bioservices, Inc. (CDMO) And Encourages Shareholders to Connect - AccessWire

Jan 12, 2025

Jan 11, 2025

Avid Bioservices (FRA:TEHN) Gross Profit : €10.7 Mil (TTM As of Oct. 2024) - GuruFocus.com

Jan 11, 2025

Symbol Lookup - GuruFocus.com

Jan 11, 2025

Jan 08, 2025

(CDMO) On The My Stocks Page - Stock Traders Daily

Jan 08, 2025

Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand - GlobeNewswire

Jan 08, 2025

Avid Bioservices Urges Shareholder Approval of Premium Buyout Deal with 63.8% Upside - StockTitan

Jan 08, 2025

Avid Bioservices (NASDAQ:CDMO) Share Price Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat

Jan 08, 2025

Jan 06, 2025

AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc.CDMO - Business Wire

Jan 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avid Bioservices, Inc. (CDMO) and Encourages Shareholders to Learn More About the Investigation - AccessWire

Jan 06, 2025

Jan 05, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire

Jan 05, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, CDMO, ROIC, SUM on Behalf of Shareholders - GlobeNewswire Inc.

Jan 05, 2025

Jan 03, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, ATSG, STAF on Behalf of Shareholders - Marketscreener.com

Jan 03, 2025

Jan 02, 2025